GB837451A - Sustained release therapeutic composition and process of preparing same - Google Patents

Sustained release therapeutic composition and process of preparing same

Info

Publication number
GB837451A
GB837451A GB5576/57A GB557657A GB837451A GB 837451 A GB837451 A GB 837451A GB 5576/57 A GB5576/57 A GB 5576/57A GB 557657 A GB557657 A GB 557657A GB 837451 A GB837451 A GB 837451A
Authority
GB
United Kingdom
Prior art keywords
medicament
mixture
sustained release
binder
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5576/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARNER CO Inc
Original Assignee
ARNER CO Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARNER CO Inc filed Critical ARNER CO Inc
Publication of GB837451A publication Critical patent/GB837451A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

A tablet to maintain a sustained release of medicament in the presence of body fluids is made from a mixture of medicament-containing granules dispersed in a medicament-free matrix, each granule consisting essentially of a mixture of a medicament and excipients consisting of a binder, a swelling agent, a hydrophobic compound solid at body temperatures and being an aluminium or alkaline-earth metal salt of higher fatty acids or a mineral wax or animal or vegetable fat and a hydrophilic compound solid at body temperatures being higher fatty acid partial esters of glycerol and propylene glycol: the matrix consisting of a mixture of equal amounts of a hydrophobic compound (as above) and an alkaline water-soluble salt of ammonium, sodium or potassium, such as trisodium phosphate. The binder may be zein or ethyl cellulose; the swelling agent may be guar gum, gum tragacanth, carboxymethyl cellulose or its sodium or potassium salts or natural clays such as bentonite. In the specific example the medicament is phenobarbitol.
GB5576/57A 1956-02-20 1957-02-19 Sustained release therapeutic composition and process of preparing same Expired GB837451A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US837451XA 1956-02-20 1956-02-20

Publications (1)

Publication Number Publication Date
GB837451A true GB837451A (en) 1960-06-15

Family

ID=22180412

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5576/57A Expired GB837451A (en) 1956-02-20 1957-02-19 Sustained release therapeutic composition and process of preparing same

Country Status (1)

Country Link
GB (1) GB837451A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322633A (en) * 1961-02-24 1967-05-30 Konink Pharmaceutische Fabrike Pharmaceutical preparations
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4344968A (en) 1978-12-09 1982-08-17 Nippon Kayaku Kabushiki Kaisha Pharmaceutical vehicle
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
US5556639A (en) * 1991-01-30 1996-09-17 Glaxo Wellcome Inc. Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5698221A (en) * 1992-07-27 1997-12-16 Patel; Suryakant Dahyabhai Water-dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
WO2013163738A1 (en) * 2012-04-30 2013-11-07 Mircea-Alexandru Mateescu Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322633A (en) * 1961-02-24 1967-05-30 Konink Pharmaceutische Fabrike Pharmaceutical preparations
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4344968A (en) 1978-12-09 1982-08-17 Nippon Kayaku Kabushiki Kaisha Pharmaceutical vehicle
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
US5556639A (en) * 1991-01-30 1996-09-17 Glaxo Wellcome Inc. Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5660860A (en) * 1991-01-30 1997-08-26 Glaxo Wellcome Inc. Water-dispersible tablets
US5698221A (en) * 1992-07-27 1997-12-16 Patel; Suryakant Dahyabhai Water-dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
WO2013163738A1 (en) * 2012-04-30 2013-11-07 Mircea-Alexandru Mateescu Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients
US9220699B2 (en) 2012-04-30 2015-12-29 Karici Diagnostics Inc. Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients

Similar Documents

Publication Publication Date Title
GB1405088A (en) Slow release formulation
ES264040A1 (en) Pharmaceutical formulations and their manufacture
GB1359614A (en) Method for the manufacture of effervescent tablets
GB837451A (en) Sustained release therapeutic composition and process of preparing same
US3121663A (en) Carbon dioxide releasing laxative suppository
GB1095985A (en) Free-flowing powders comprising choline chloride and a method for their manufacture
GB953626A (en) Enteric-coated tablets of dextran sulphate ester and method of preparation thereof
GB630439A (en) Improvements in or relating to pharmaceutical preparations
US2282290A (en) Anthelmintic tablet
GB847370A (en) Improvements in or relating to preparations for herbicidal, insecticidal or fertilizing purposes
GB1073772A (en) Improvements in and relating to dental impression materials
GB739800A (en) Aqueous pharmaceutical solutions of reserpine for parenteral administration
GB1460302A (en) Tablet formulation
GB945981A (en) Improvements in animal feeding stuffs
GB757155A (en) Novel haemostatic compositions
ES354048A1 (en) Npn-composition for ruminant animals
GB573589A (en) Improvements in or relating to the manufacture of alginic materials
GB884576A (en) Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof
GB1403062A (en) Composition for treating burns and scalds
GB727870A (en) Derivatives of sym-triacetylbenzene
GB973681A (en) Tobacco compositions and preparation thereof
GB709283A (en) Gelatine capsules containing chloral hydrate
GB751440A (en) Improved muscle relaxant composition
GB1190838A (en) Improvements in or relating to Dental Impression Materials
GB949287A (en) Dry solid curing salt composition